Metachondromatosis

Last updated
Metachondromatosis
Other namesMETCDS [1]
Autosomal dominant - en.svg
Metachondromatosis has an autosomal dominant pattern of inheritance.

Metachondromatosis is an autosomal dominant, incompletely penetrant [2] genetic disease affecting the growth of bones, leading to exostoses primarily in the hands and feet as well as enchondromas of long bone metaphyses and iliac crests. [3] This syndrome affects mainly tubular bones, though it can also involve the vertebrae, small joints, and flat bones. [4] The disease is thought to affect exon 4 of the PTPN11 gene. [2] Metachondromatosis is believed to be caused by an 11 base pair deletion resulting in a frameshift and nonsense mutation. The disease was discovered and named in 1971 by Pierre Maroteaux, a French physician, when he observed two families with skeletal radiologic features with exostoses and Ollier disease. [5] The observation of one family with five affected people led to the identification of the disease as autosomal dominant. [5] There have been less than 40 cases of the disease reported to date. [6] [7]

Contents

Signs and Symptoms

Metachondromatosis is identified by the presence of both multiple enchondromas and osteochondromas in the patient, although other less characteristic symptoms are often associated with the disease.  The symptoms usually become apparent in the first 10 years of life and disappear later in life. [8] The symptoms of Metachondromatosis are seen as follows:

Enchondromas

Enchondromas are benign tumors present on the inside of bones. In Metachondromatosis, enchondromas involves the iliac crests and metaphyses of long bones, often the proximal femur. Usually, these tumors are painless; however, when present in the hands or feet, or in multiple lesions, as typically seen, bone deformity can occur. [8]

Osteochondromas

Osteochondromas are benign tumors located on the surface of bone near growth plates.  These tumors also often in the hands and feet, primarily affecting the digits of fingers and toes.  These tumors tend to subside after 10-20 years of life. [8]   These tumors can become painful if they pressure sensitive tissue or nerves. [8]   Metachondromatosis is differentiated from hereditary multiple osteochondromas by the location of the location of Osteochondromas tumors as well as the lack of bone-shortening. [8]

Abnormality of epiphysis morphology

The epiphysis is the rounded end part of bone. The structure of the epiphysis can be abnormal in metachondromatosis[ citation needed ].

Abnormality of the metaphysis

The metaphysis is wide portion of a long bone, and also has abnormal structure in the disease.[ citation needed ]

Avascular necrosis

Avascular necrosis is the death of bone due to a decreased blood supply.[ citation needed ]

Bone pain

People with metachondromatosis often experience bone pain due to abnormal bone shapes.[ citation needed ]

Cranial nerve paralysis

Cranial nerve paralysis can affect the functions associated with the cranial nerve. [9]

Genetics

Metachondromatosis is inherited in an autosomal dominant manner, needing only one copy of the defective gene to cause the disorder. [2] The cause of the disorder has been linked to an 11 base pair deletion in exon four of the PTPN11 gene [2] (12q24.13). [10] This deletion causes a frameshift, resulting in a nonsense mutation with a premature stop codon. This causes severe truncation and loss of function in the gene’s protein product, tyrosine phosphatase SHP-2. [2]

SHP-2 plays an important role in regulating expression of the Indian Hedgehog gene (IHH), [11] which is associated with differentiation in chondrocytes (specialized cells in cartilage tissue). [7] Individuals affected by metachondromatosis generally demonstrate high levels of IHH expression, which is believed to be responsible for the tumor growth. [11]

Given that the mutation causes a loss of protein function and displays a dominant inheritance pattern, it is hypothesized that individuals homozygous for the disorder would display greater symptoms than heterozygous individuals, though insufficient data is available to evaluate these claims due to the rarity of the disease. [11] Conversely, some heterozygous individuals have shown minimal effects, leading to the disorder’s designation as incompletely penetrant. [2] The cause of this is not fully understood, but may be due to other factors influencing IHH expression. [2] [11]

Diagnosis

Because of its rarity, metachondromatosis is often a difficult disease to recognize and diagnose. Diagnosis can be made based on clinical observations and radiographic findings as well as family history. [12] Using radiographic methods, osteochondromas can be seen at the metaphyses of the short tubular bones, such as those in the hands and feet, pointing towards the joints. [6] Enchondromas would also be visible along with the osteochondromas. The differential diagnosis includes hereditary multiple osteochondromas. This is a condition in which the long bones are primarily affected, and the lesions point away from the joint or growth plate. This may also result in the shortening or deformity of the affected bones. [6] Since metachondromatosis is hereditary, genetic counseling can be offered to patients and their families. Some available genetic tests for metachondromatosis are sequence analysis of the entire coding region, targeted variant analysis, deletion/duplication analysis, and a sequence analysis of select exons associated with the disorder. [13]

Treatment

Osteochondromas are usually painless, and in many cases, they spontaneously regress after the first or second decade of life. Most patients are asymptomatic, making medical intervention unnecessary. However, in extreme cases such as severe malalignment of the fingers and toes, surgery can be used to remove the osteochondromas. [6]

Epidemiology

Metachondromatosis is very rare, occurring in less than 1 in 1,000,000 people. Fewer than 40 cases have been reported around the world to date. [6] [14]

Related Research Articles

Gardners syndrome Medical condition

Gardner's syndrome is a subtype of familial adenomatous polyposis (FAP). Gardner syndrome is an autosomal dominant form of polyposis characterized by the presence of multiple polyps in the colon together with tumors outside the colon. The extracolonic tumors may include osteomas of the skull, thyroid cancer, epidermoid cysts, fibromas, as well as the occurrence of desmoid tumors in approximately 15% of affected individuals.

Malouf syndrome is a congenital disorder that causes one or more of the following symptoms: mental retardation, ovarian dysgenesis, congestive cardiomyopathy, broad nasal base, blepharoptosis, and bone abnormalities, and occasionally marfanoid habitus.

Mulibrey nanism Medical condition

Mulibrey nanism is a rare autosomal recessive congenital disorder. It causes severe growth failure along with abnormalities of the heart, muscle, liver, brain and eye. TRIM37 is responsible for various cellular functions including developmental patterning.

Ring chromosome Chromosome whose ends have fused together to form a ring

A ring chromosome is an aberrant chromosome whose ends have fused together to form a ring. Ring chromosomes were first discovered by Lilian Vaughan Morgan in 1926. A ring chromosome is denoted by the symbol r in human genetics and R in Drosophila genetics. Ring chromosomes may form in cells following genetic damage by mutagens like radiation, but they may also arise spontaneously during development.

Aceruloplasminemia Medical condition

Aceruloplasminemia is a rare autosomal recessive disorder in which the liver can not synthesis the protein ceruloplasmin properly, which is needed to transport copper around the blood. Copper deficiency in the brain results in neurological problems that generally appear in adulthood and worsen over time. .

Bannayan–Riley–Ruvalcaba syndrome Medical condition

Bannayan–Riley–Ruvalcaba syndrome (BRRS) is a rare overgrowth syndrome and hamartomatous disorder with occurrence of multiple subcutaneous lipomas, macrocephaly and hemangiomas. The disease is inherited in an autosomal dominant manner. The disease belongs to a family of hamartomatous polyposis syndromes, which also includes Peutz–Jeghers syndrome, juvenile polyposis and Cowden syndrome. Mutation of the PTEN gene underlies this syndrome, as well as Cowden syndrome, Proteus syndrome, and Proteus-like syndrome, these four syndromes are referred to as PTEN Hamartoma-Tumor Syndromes.

Lucey–Driscoll syndrome Medical condition

Lucey–Driscoll syndrome is an autosomal recessive metabolic disorder affecting enzymes involved in bilirubin metabolism. It is one of several disorders classified as a transient familial neonatal unconjugated hyperbilirubinemia.

Acromicric dysplasia is an extremely rare inherited disorder characterized by abnormally short hands and feet, growth retardation and delayed bone maturation leading to short stature. Most cases have occurred randomly for no apparent reason (sporadically). However, autosomal dominant inheritance has not been ruled out.

SCARF syndrome Medical condition

SCARF syndrome is a rare syndrome characterized by skeletal abnormalities, cutis laxa, craniostenosis, ambiguous genitalia, psychomotor retardation, and facial abnormalities. These characteristics are what make up the acronym SCARF. It shares some features with Lenz-Majewski hyperostotic dwarfism. It is a very rare disease with an incidence rate of approximately one in a million newborns. It has been clinically described in two males who were maternal cousins, as well as a 3-month-old female. Babies affected by this syndrome tend to have very loose skin, giving them an elderly facial appearance. Possible complications include dyspnea, abdominal hernia, heart disorders, joint disorders, and dislocations of multiple joints. It is believed that this disease's inheritance is X-linked recessive.

TNF receptor associated periodic syndrome Medical condition

TNF receptor associated periodic syndrome (TRAPS) is a periodic fever syndrome associated with mutations in a receptor for the molecule tumor necrosis factor (TNF) that is inheritable in an autosomal dominant manner. Individuals with TRAPS have episodic symptoms such as recurrent high fevers, rash, abdominal pain, joint/muscle aches and puffy eyes.

Maffucci syndrome Medical condition

Maffucci syndrome is a very rare disorder in which multiple benign tumors of cartilage develop within the bones. The tumors most commonly appear in the bones of the hands, feet, and limbs, causing bone deformities and short limbs.

Naegeli–Franceschetti–Jadassohn syndrome Medical condition

Naegeli–Franceschetti–Jadassohn syndrome (NFJS), also known as chromatophore nevus of Naegeli and Naegeli syndrome, is a rare autosomal dominant form of ectodermal dysplasia, characterized by reticular skin pigmentation, diminished function of the sweat glands, the absence of teeth and hyperkeratosis of the palms and soles. One of the most striking features is the absence of fingerprint lines on the fingers.

Dermatopathia pigmentosa reticularis Medical condition

Dermatopathia pigmentosa reticularis(DPR) is a rare, autosomal dominant congenital disorder that is a form of ectodermal dysplasia. Dermatopathia pigmentosa reticularis is composed of the triad of generalized reticulate hyperpigmentation, noncicatricial alopecia, and onychodystrophy. DPR is a non life-threatening disease that largely affects the skin, hair, and nails. It has also been identified as a keratin disorder. Historically, as of 1992, only 10 cases had been described in world literature; however, due to recent advances in genetic analysis, five additional families studied in 2006 have been added to the short list of confirmed cases.

Upington disease Medical condition

Upington disease is an extremely rare autosomal dominant malformation disorder. It has only one published source claiming its existence in three generations of one family from South Africa.

Orofaciodigital syndrome 1 Medical condition

Orofaciodigital syndrome 1 (OFD1), also called Papillon-League and Psaume syndrome, is an X-linked congenital disorder characterized by malformations of the face, oral cavity, and digits with polycystic kidney disease and variable involvement of the central nervous system.

GRACILE syndrome Medical condition

GRACILE syndrome is a very rare lethal autosomal recessive genetic disorder, one of the Finnish heritage diseases. GRACILE syndrome has also been found in the UK and Sweden, but not nearly as much as in Finland. It is caused by a mutation in the BCS1L gene and it occurs in approximately 1 out of 50,000 live births in Finnish people. To date, there have only been 32 cases of GRACILE syndrome reported.

Parastremmatic dwarfism Medical condition

Parastremmatic dwarfism is a rare bone disease that features severe dwarfism, thoracic kyphosis, a distortion and twisting of the limbs, contractures of the large joints, malformations of the vertebrae and pelvis, and incontinence. The disease was first reported in 1970 by Leonard Langer and associates; they used the term parastremmatic from the Greek parastremma, or distorted limbs, to describe it. On X-rays, the disease is distinguished by a "flocky" or lace-like appearance to the bones. The disease is congenital, which means it is apparent at birth. It is caused by a mutation in the TRPV4 gene, located on chromosome 12 in humans. The disease is inherited in an autosomal dominant manner.

Acromesomelic dysplasia is a rare skeletal disorder that causes abnormal bone and cartilage development, leading to shortening of the forearms, lower legs, hands, feet, fingers, and toes. Five different genetic mutations have been implicated in the disorder. Treatment is individualized but is generally aimed at palliating symptoms, for example, treatment of kyphosis and lumbar hyperlordosis.

Blepharophimosis-ptosis-esotropia-syndactyly-short stature syndrome Very rare genetic disorder

Blepharophimosis-ptosis-esotropia-syndactyly-short stature syndrome is a very rare genetic and congenital disorder which is characterized by blepharophimosis, ptosis, V-esotropia, foot syndactyly, extra-ocular and frontal muscles weakness, low height/short stature, prognathism, and synophrys.

References

  1. ↑ "Metachondromatosis | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 27 June 2019.
  2. 1 2 3 4 5 6 7 Sobreira NL, Cirulli ET, Avramopoulos D, et al. (2010). "Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene". PLOS Genet. 6 (6): e1000991. doi:10.1371/journal.pgen.1000991. PMC   2887469 . PMID   20577567.
  3. ↑ Sobreira, Nara L. M.; Cirulli, Elizabeth T.; Avramopoulos, Dimitrios; Wohler, Elizabeth; Oswald, Gretchen L.; Stevens, Eric L.; Ge, Dongliang; Shianna, Kevin V.; Smith, Jason P.; Maia, Jessica M.; Gumbs, Curtis E. (2010-06-17). "Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene". PLOS Genetics. 6 (6): e1000991. doi:10.1371/journal.pgen.1000991. ISSN   1553-7404. PMC   2887469 . PMID   20577567.
  4. ↑ Hunter AG, Kozlowski K, Hochberger O (1995). "Metachondromatosis". Can Assoc Radiol J. 46 (3): 202–8. PMID   7538882.
  5. 1 2 "OMIM Entry - # 156250 - METACHONDROMATOSIS; METCDS". www.omim.org. Retrieved 2022-03-24.
  6. 1 2 3 4 5 RESERVED, INSERM US14-- ALL RIGHTS. "Orphanet: Metachondromatosis". www.orpha.net. Retrieved 2022-03-24.
  7. 1 2 Gonzalez-Quevedo, Rosa (31 January 2005). "Receptor tyrosine phosphatase–dependent cytoskeletal remodeling by the hedgehog-responsive gene MIM/BEG4". Journal of Cell Biology. 168 (3): 453–463. doi:10.1083/jcb.200409078. PMC   2171717 . PMID   15684034.
  8. 1 2 3 4 5 "Metachondromatosis | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 2022-03-24.
  9. ↑ "Cranial Nerve Palsy - American Association for Pediatric Ophthalmology and Strabismus". aapos.org. Retrieved 2022-03-24.
  10. ↑ "OMIM Entry * 176876 - PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 11; PTPN11". omim.org. Retrieved 23 March 2022.
  11. 1 2 3 4 Yang, Wetian (17 July 2013). "Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling". Nature. 499 (1): 491–495. Bibcode:2013Natur.499..491Y. doi:10.1038/nature12396. PMC   4148013 . PMID   23863940.
  12. ↑ "Metachondromatosis | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 2022-03-24.
  13. ↑ "Metachondromatosis - Conditions - GTR - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2022-03-24.
  14. ↑ www.malacards.org https://www.malacards.org/card/metachondromatosis . Retrieved 2022-03-24.{{cite web}}: Missing or empty |title= (help)


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.